Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-02-04Clinical Trial Update: Orthomolecular Therapy and Asthma in Children [Phase 2]
Phase 2 clinical trial update on orthomolecular therapy for asthma in children; the current status of the trial is unknown.
-
CLINICAL_TRIALS trial_result · 2011-01-31Clinical Trial Update: Effect of Fish Oil and Vitamin C on Exercise-Induced Bronchoconstriction and Airway Inflammation in Asthma [Phase 1]
Phase 1 trial update investigating whether fish oil and vitamin C reduce exercise-induced bronchoconstriction and airway inflammation in ast…
-
CLINICAL_TRIALS trial_result · 2011-01-31Clinical Trial Update: Repeat Dose Safety Study for Compound to Treat Asthma [Phase 1]
A Phase 1 repeat-dose safety study for a compound intended to treat asthma has been completed.
-
CLINICAL_TRIALS trial_result · 2011-01-28Clinical Trial Update: An Observational Study to Investigate How Patients Experience the Ability to Adjust Their Asthma Maintenance Medication
This completed observational study examined how patients experience adjusting their asthma maintenance medications.
-
CLINICAL_TRIALS trial_result · 2011-01-27Clinical Trial Update: A Study of the Treatment-Sparing Effects of AEROVANT™ AER 001 Inhalation Powder in Asthma Patients, AEROTRIAL [Phase 2]
Phase 2 study updating on the treatment-sparing effects of AEROVANT AER 001 inhalation powder in asthma patients.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler® [Phase 3]
A Phase 3 trial comparing asthma control with Symbicort Turbuhaler alone versus in combination with Pulmicort Turbuhaler and Terbutaline Tur…
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma [Phase 3]
A Phase 3 study evaluating the safety and efficacy of Symbicort Turbuhaler (budesonide/formoterol) in Japanese patients with asthma has comp…
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: The Prednisone-sparing Effect of Anti-IL-5 Antibody (SB-240563) [Phase 2]
Phase 2 trial evaluating the prednisone-sparing effect of the anti-IL-5 antibody SB-240563 in asthma has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 80/4.5 [Phase 3]
In a Phase 3 study, the Symbicort combination (budesonide/formoterol) is evaluated against its individual components, budesonide and formote…
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM [Phase 3]
This update reports the efficacy results from a Phase 3 trial of Symbicort pMDI administered once daily in adolescents and adults with asthm…
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Efficacy of Symbicort pMDI Administered Once Daily in Children and Adolescents During 12 Weeks - SPROUT [Phase 3]
This update summarizes the efficacy findings from a Phase 3 SPROUT trial evaluating once-daily Symbicort inhaler in children and adolescents…
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Relative Bronchodilating Effects of Formoterol When Administered Via Symbicort Pressurized Metered-dose Inhaler (pMDI) or Oxis Turbuhaler [Phase 2]
Phase 2 trial evaluating the relative bronchodilating effects of formoterol when delivered via Symbicort pMDI versus Oxis Turbuhaler in stab…
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Symbicort Onset of Action 2 [Phase 3]
Phase 3 clinical trial update for Symbicort assessing onset of action in asthma; the study has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults [Phase 3]
Phase 3 trial (SYMPHONIE) comparing a Symbicort single inhaler to conventional best practice for persistent asthma in adolescents and adults…
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: New Version Pulmicort Turbuhaler USA Adults [Phase 3]
A Phase 3 trial evaluating a new version of Pulmicort Turbuhaler for asthma in US adults has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: SALTO - Symbicort Single Inhaler Therapy Use in Adolescent Adults and Adults With Persistent Asthma [Phase 3]
A Phase 3 trial evaluating Symbicort as a single inhaler therapy for persistent asthma in adolescents and adults has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Efficacy & Safety of Symbicort® TURBUHALER® 160/4.5 µg Twice Daily & Pulmicort® TURBUHALER® 200 µg Twice Daily + Theolong® Tablet 200 mg Twice Daily in Japanese Asthmatic Patients [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Symbicort TURBUHALER 160/4.5 µg BID and Pulmicort TURBUHALER 200 µg BID plus Theolong Ta…
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Titratable Dosing in Moderate to Severe Asthmatics [Phase 3]
AstraZeneca-sponsored Phase 3 trial evaluating titratable dosing in moderate-to-severe asthma has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Gemini Symbicort pMDI [Phase 3]
Clinical trial update reports completion of a Phase 3 study of Gemini Symbicort pMDI for mild or moderate asthma.
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 160/4.5 [Phase 3]
Phase 3 trial evaluating the efficacy of Symbicort versus its monocomponents in asthma.
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: MONO: Symbicort® Single Inhaler Therapy and Conventional Best Standard Treatment for the Treatment of Persistent Asthma in Adolescents and Adults [Phase 4]
This Phase 4 trial compares Symbicort single inhaler therapy to conventional best standard treatment for persistent asthma in adolescents an…
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: SHARE - Symbicort and Health Economics in a Real Life Evaluation [Phase 3]
Phase 3 SHARE trial completed evaluating Symbicort (budesonide/formoterol) with a health economics analysis in real-world asthma management.
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mg [Phase 3]
A Phase 3 trial comparing efficacy and safety of Symbicort Turbuhaler, Seretide Diskus 50/500 µg, and Terbutaline Turbuhaler in asthma patie…
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Cost-effectiveness Study of Symbicort as Maintenance and Reliever Therapy (SMART)
A completed cost-effectiveness study evaluating Symbicort as maintenance and reliever therapy (SMART) for asthma.
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: SMILDA - Symbicort®Turbuhaler® Allergan Challenge Study in Allergic Patients With Mild Asthma [Phase 3]
A Phase 3 trial of Symbicort Turbuhaler in allergic patients with mild asthma has completed.